|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent REGN insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why REGN insider buys are important for investors to follow.
Date | Insider | Price | Amount |
8-25-2017 Insider Buy |
Sanofi
|
$481.36
CAGR »
|
$34,840,132.96 72,378 shares |
8-24-2017 Insider Buy |
Sanofi
|
$480.93
CAGR »
|
$80,033,622.17 166,415 shares |
6-2-2017 Insider Buy |
Sanofi
|
$478.17
CAGR »
|
$65,055,558.00 136,050 shares |
1-11-2017 Insider Buy |
Sanofi
|
$369.71
CAGR »
|
$32,274,871.70 87,298 shares |
6-14-2016 Insider Buy |
Sanofi >10% Owner |
$363.86
CAGR »
|
$23,552,858.70 64,731 shares |
2-17-2016 Insider Buy |
Sanofi
|
$392.46
CAGR »
|
$63,247,909.95 161,157 shares |
1-12-2016 Insider Buy |
Sanofi >10% Owner |
$465.04
CAGR »
|
$39,034,660.20 83,938 shares |
10-6-2015 Insider Buy |
Sanofi >10% Owner |
$459.71
CAGR »
|
$37,024,196.88 80,538 shares |
10-6-2015 Insider Buy |
Sanofi >10% Owner |
$472.33
CAGR »
|
$5,214,518.70 11,040 shares |
9-23-2015 Insider Buy |
Sanofi >10% Owner |
$534.67
CAGR »
|
$78,708,569.98 147,209 shares |
7-27-2015 Insider Buy |
Sanofi >10% Owner |
$537.48
CAGR »
|
$5,718,271.92 10,639 shares |
12-24-2014 Insider Buy |
Sanofi >10% Owner |
$393.21
CAGR »
|
$79,215,643.29 201,459 shares |
11-25-2014 Insider Buy |
Christine A. Poon Director |
$410.00
CAGR »
|
$164,000.00 400 shares |
10-16-2014 Insider Buy |
Sanofi >10% Owner |
$335.35
CAGR »
|
$40,955,057.18 122,127 shares |
10-15-2014 Insider Buy |
Sanofi >10% Owner |
$328.16
CAGR »
|
$51,970,264.69 158,368 shares |
9-16-2014 Insider Buy |
Sanofi >10% Owner |
$349.26
CAGR »
|
$11,077,574.05 31,717 shares |
9-15-2014 Insider Buy |
Sanofi >10% Owner |
$345.15
CAGR »
|
$48,539,727.77 140,632 shares |
7-15-2014 Insider Buy |
Sanofi >10% Owner |
$314.92
CAGR »
|
$40,656,176.28 129,100 shares |
7-14-2014 Insider Buy |
Sanofi >10% Owner |
$316.80
CAGR »
|
$95,038,632.66 300,000 shares |
7-10-2014 Insider Buy |
Sanofi >10% Owner |
$311.08
CAGR »
|
$54,439,072.93 175,000 shares |
7-9-2014 Insider Buy |
Sanofi >10% Owner |
$309.76
CAGR »
|
$107,798,054.92 348,000 shares |
7-7-2014 Insider Buy |
Sanofi >10% Owner |
$312.37
CAGR »
|
$111,422,740.60 356,700 shares |
7-1-2014 Insider Buy |
Sanofi >10% Owner |
$300.19
CAGR »
|
$63,761,420.56 212,400 shares |
7-2-2014 Insider Buy |
Sanofi >10% Owner |
$307.25
CAGR »
|
$65,259,551.56 212,400 shares |
6-30-2014 Insider Buy |
Sanofi >10% Owner |
$281.17
CAGR »
|
$73,779,571.63 262,400 shares |
5-21-2014 Insider Buy |
Christine A. Poon Director |
$291.90
CAGR »
|
$74,434.50 255 shares |
5-19-2014 Insider Buy |
Sanofi >10% Owner |
$300.04
CAGR »
|
$57,233,715.78 190,751 shares |
3-27-2014 Insider Buy |
Sanofi >10% Owner |
$311.01
CAGR »
|
$95,463,962.61 306,945 shares |
3-28-2014 Insider Buy |
Sanofi >10% Owner |
$306.73
CAGR »
|
$94,149,582.77 306,945 shares |
3-24-2014 Insider Buy |
Sanofi >10% Owner |
$307.91
CAGR »
|
$94,511,734.27 306,945 shares |
3-21-2014 Insider Buy |
Sanofi >10% Owner |
$321.22
CAGR »
|
$98,008,221.80 305,115 shares |
3-20-2014 Insider Buy |
Sanofi >10% Owner |
$328.33
CAGR »
|
$22,229,161.88 67,703 shares |
3-17-2014 Insider Buy |
Sanofi >10% Owner |
$328.46
CAGR »
|
$38,006,448.46 115,711 shares |
3-12-2014 Insider Buy |
Sanofi >10% Owner |
$334.69
CAGR »
|
$73,964,411.74 220,995 shares |
3-11-2014 Insider Buy |
Sanofi >10% Owner |
$330.41
CAGR »
|
$125,730,771.00 380,532 shares |
3-7-2014 Insider Buy |
Sanofi >10% Owner |
$328.72
CAGR »
|
$49,399,201.55 150,277 shares |
3-7-2014 Insider Buy |
Sanofi >10% Owner |
$332.51
CAGR »
|
$80,405,733.03 241,818 shares |
3-3-2014 Insider Buy |
Sanofi >10% Owner |
$338.12
CAGR »
|
$85,070,118.03 251,594 shares |
2-7-2014 Insider Buy |
Sanofi >10% Owner |
$286.78
CAGR »
|
$48,325,844.66 168,511 shares |
2-5-2014 Insider Buy |
Sanofi >10% Owner |
$284.12
CAGR »
|
$112,871,896.53 397,264 shares |
2-3-2014 Insider Buy |
Sanofi >10% Owner |
$283.78
CAGR »
|
$59,303,101.83 208,972 shares |
1-28-2014 Insider Buy |
Sanofi >10% Owner |
$275.90
CAGR »
|
$43,570,365.16 157,920 shares |
10-13-2010 Insider Buy |
Sanofi-aventis >10% Owner |
$28.00
CAGR »
|
$28,487,228.00 1,017,401 shares |
Also See: Institutional Holders of REGN
Also See: SEC filings
Below we present the annualized performance delivered by REGN stock since 8-25-2017 (the date of the most recent
insider purchase). The performance of the investment from the time REGN insider buying occurred is the ultimate
test of whether insiders were right about REGN being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
08/28/2017 |
|
End date: |
04/19/2024 |
|
Start price/share: |
$479.22 |
|
End price/share: |
$896.82 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
87.14% |
|
Average Annual Total Return: |
9.89% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$18,716.80 |
|
Years: |
6.65 |
|
REGN Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent REGN insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding REGN
|
|